12
Participants
Start Date
July 31, 2009
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
LBH 589
"LBH589 three-times-a-week (doses will be at least 2 days apart, e.g. Monday, Wednesday, Friday), until disease progression or intolerable toxicities LBH589 will start the week prior to the first pemetrexed cycle and PD studies will be performed (week -1).~Dose level: 1 LBH589: 10 mg Pemetrexed: 500 mg/m2~Dose level: 2 LBH589: 15 mg Pemetrexed: 500 mg/m2~Dose level: 3 LBH589: 20 mg Pemetrexed: 500 mg/m2~Dose level: 4 LBH589: 30 mg Pemetrexed: 500 mg/m2"
Pemetrexed
Pemetrexed 500mg/m2 IV, day 1, every 21 days, on the first day of the week LBH589 is given.
Hillman Cancer Center, Pittsburgh
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
University of Pittsburgh
OTHER